Lipid metabolism and toxicity in the heart

Cell Metabolism

Volumn 15, Issue 6, 2012, Pages 805-812

  Goldberg, Ira J ^a   Trent, Chad M ^a   Schulze, P Christian ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL;

CARDIOTOXICITY; CIRCULATION; HEART DISEASE; HEART MUSCLE CELL; LIPID METABOLISM; LIPID STORAGE; LIPOTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOMYOPATHIES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS; HUMANS; LIPID METABOLISM; MYOCARDIUM; OBESITY;

EID: 84862008999     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.04.006     Document Type: Review

References (97)

1. Augustus, A., Yagyu, H., Haemmerle, G., Bensadoun, A., Vikramadithyan, R.K., Park, S.Y., Kim, J.K., Zechner, R., and Goldberg, I.J. (2004). Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J. Biol. Chem. 279, 25050-25057. (Pubitemid 38756753)
2. Ballard, F.B., Danforth, W.H., Naegle, S., and Bing, R.J. (1960). Myocardial metabolism of fatty acids. J. Clin. Invest. 39, 717-723.
3. Banke, N.H., Wende, A.R., Leone, T.C., O'Donnell, J.M., Abel, E.D., Kelly, D.P., and Lewandowski, E.D. (2010). Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ. Res. 107, 233-241.
4. Barouch, L.A., Berkowitz, D.E., Harrison, R.W., O'Donnell, C.P., and Hare, J.M. (2003). Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108, 754-759. (Pubitemid 36999263)
5. Bartels, E.D., Nielsen, J.M., Hellgren, L.I., Ploug, T., and Nielsen, L.B. (2009). Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS ONE 4, e5300.
6. Bharadwaj, K.G., Hiyama, Y., Hu, Y., Huggins, L.A., Ramakrishnan, R., Abumrad, N.A., Shulman, G.I., Blaner, W.S., and Goldberg, I.J. (2010). Chylomicronand VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J. Biol. Chem. 285, 37976-37986.
7. Borradaile, N.M., Han, X., Harp, J.D., Gale, S.E., Ory, D.S., and Schaffer, J.E. (2006). Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 47, 2726-2737. (Pubitemid 44936086)
8. Bosma, M., Minnaard, R., Sparks, L.M., Schaart, G., Losen, M., de Baets, M.H., Duimel, H., Kersten, S., Bickel, P.E., Schrauwen, P., et al. (2011). The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria. Histochem. Cell Biol. 137, 205-216.
9. Boudina, S., and Abel, E.D. (2007). Diabetic cardiomyopathy revisited. Circulation 115, 3213-3223. (Pubitemid 47012236)
10. Boudina, S., Sena, S., O'Neill, B.T., Tathireddy, P., Young, M.E., and Abel, E.D. (2005). Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112, 2686-2695. (Pubitemid 41532606)
11. Buchanan, J., Mazumder, P.K., Hu, P., Chakrabarti, G., Roberts, M.W., Yun, U.J., Cooksey, R.C., Litwin, S.E., and Abel, E.D. (2005). Reduced cardiac efficiency and altered substrate metabolismprecedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146, 5341-5349. (Pubitemid 41653047)
12. Burkart, E.M., Sambandam, N., Han, X., Gross, R.W., Courtois, M., Gierasch, C.M., Shoghi, K., Welch, M.J., and Kelly, D.P. (2007). Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J. Clin. Invest. 117, 3930-3939. (Pubitemid 350224102)
13. Chang, B.H., Li, L., Paul, A., Taniguchi, S., Nannegari, V., Heird, W.C., and Chan, L. (2006). Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell. Biol. 26, 1063-1076. (Pubitemid 43146498)
14. Cheng, L., Ding, G., Qin, Q., Huang, Y., Lewis, W., He, N., Evans, R.M., Schneider, M.D., Brako, F.A., Xiao, Y., et al. (2004). Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10, 1245-1250. (Pubitemid 39540443)
15. Chiu, H.C., Kovacs, A., Blanton, R.M., Han, X., Courtois, M., Weinheimer, C.J., Yamada, K.A., Brunet, S., Xu, H., Nerbonne, J.M., et al. (2005). Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96, 225-233. (Pubitemid 40209370)
16. Chiu, H.C., Kovacs, A., Ford, D.A., Hsu, F.F., Garcia, R., Herrero, P., Saffitz, J.E., and Schaffer, J.E. (2001). A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107, 813-822. (Pubitemid 32274034)
17. Christoffersen, C., Bollano, E., Lindegaard, M.L., Bartels, E.D., Goetze, J.P., Andersen, C.B., and Nielsen, L.B. (2003). Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144, 3483-3490. (Pubitemid 36904426)
18. Coburn, C.T., Knapp, F.F., Jr., Febbraio, M., Beets, A.L., Silverstein, R.L., and Abumrad, N.A. (2000). Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275, 32523-32529.
19. Duncan, J.G., Bharadwaj, K.G., Fong, J.L., Mitra, R., Sambandam, N., Courtois, M.R., Lavine, K.J., Goldberg, I.J., and Kelly, D.P. (2010). Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation 121, 426-435.
20. Dyck, J.R., Hopkins, T.A., Bonnet, S., Michelakis, E.D., Young, M.E., Watanabe, M., Kawase, Y., Jishage, K., and Lopaschuk, G.D. (2006). Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 114, 1721-1728. (Pubitemid 44607120)
21. Ellis, J.M., Li, L.O., Wu, P.C., Koves, T.R., Ilkayeva, O., Stevens, R.D., Watkins, S.M., Muoio, D.M., and Coleman, R.A. (2010). Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis. Cell Metab. 12, 53-64.
22. Ellis, J.M., Mentock, S.M., Depetrillo, M.A., Koves, T.R., Sen, S., Watkins, S.M., Muoio, D.M., Cline, G.W., Taegtmeyer, H., Shulman, G.I., et al. (2011). Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy. Mol. Cell. Biol. 31, 1252-1262.
23. Ernande, L., Rietzschel, E.R., Bergerot, C., De Buyzere, M.L., Schnell, F., Groisne, L., Ovize, M., Croisille, P., Moulin, P., Gillebert, T.C., and Derumeaux, G. (2010). Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23, 1266-1272.
24. Finck, B.N., Han, X., Courtois, M., Aimond, F., Nerbonne, J.M., Kovacs, A., Gross, R.W., and Kelly, D.P. (2003). A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. USA 100, 1226-1231. (Pubitemid 36183984)
25. Finck, B.N., Lehman, J.J., Leone, T.C., Welch, M.J., Bennett, M.J., Kovacs, A., Han, X., Gross, R.W., Kozak, R., Lopaschuk, G.D., and Kelly, D.P. (2002). The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109, 121-130. (Pubitemid 34052548)
26. Fukuchi, K., Nozaki, S., Yoshizumi, T., Hasegawa, S., Uehara, T., Nakagawa, T., Kobayashi, T., Tomiyama, Y., Yamashita, S., Matsuzawa, Y., and Nishimura, T. (1999). Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J. Nucl. Med. 40, 239-243. (Pubitemid 29077084)
27. Georgiadi, A., Lichtenstein, L., Degenhardt, T., Boekschoten, M.V., van Bilsen, M., Desvergne, B., Müller, M., and Kersten, S. (2010). Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ. Res. 106, 1712-1721.
28. Goodwin, G.W., Taylor, C.S., and Taegtmeyer, H. (1998). Regulation of energy metabolism of the heart during acute increase in heart work. J. Biol. Chem. 273, 29530-29539. (Pubitemid 28509960)
29. Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006). Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737.
30. Haemmerle, G., Moustafa, T., Woelkart, G., Büttner, S., Schmidt, A., van de Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P.C., Zierler, K., et al. (2011). ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-a and PGC-1. Nat. Med. 17, 1076-1085.
31. Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Gøtzsche, L., Nielsen, R., Nielsen-Kudsk, J.E., Nielsen, S.S., Nielsen, T.T., Eiskjær, H., et al. (2010). Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am. J. Physiol. Heart Circ. Physiol. 299, H1220-H1225.
32. Hammer, S., Snel, M., Lamb, H.J., Jazet, I.M., van der Meer, R.W., Pijl, H., Meinders, E.A., Romijn, J.A., de Roos, A., and Smit, J.W. (2008). Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol. 52, 1006-1012.
33. Herrero, P., Peterson, L.R., McGill, J.B., Matthew, S., Lesniak, D., Dence, C., and Gropler, R.J. (2006). Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J. Am. Coll. Cardiol. 47, 598-604. (Pubitemid 43170851)
34. Holland, W.L., Miller, R.A., Wang, Z.V., Sun, K., Barth, B.M., Bui, H.H., Davis, K.E., Bikman, B.T., Halberg, N., Rutkowski, J.M., et al. (2011). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63.
35. Hue, L., and Taegtmeyer, H. (2009). The Randle cycle revisited: a new head for an old hat. Am. J. Physiol. Endocrinol. Metab. 297, E578-E591.
36. Irie, H., Krukenkamp, I.B., Brinkmann, J.F., Gaudette, G.R., Saltman, A.E., Jou, W., Glatz, J.F., Abumrad, N.A., and Ibrahimi, A. (2003). Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc. Natl. Acad. Sci. USA 100, 6819-6824. (Pubitemid 36666663)
37. Kankaanpää, M., Lehto, H.R., Pärkkä, J.P., Komu, M., Viljanen, A., Ferrannini, E., Knuuti, J., Nuutila, P., Parkkola, R., and Iozzo, P. (2006). Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J. Clin. Endocrinol. Metab. 91, 4689-4695. (Pubitemid 44833458)
38. Kannel, W.B., Hjortland, M., and Castelli, W.P. (1974). Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34, 29-34.
39. Koonen, D.P., Febbraio, M., Bonnet, S., Nagendran, J., Young, M.E., Michelakis, E.D., and Dyck, J.R. (2007). CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation 116, 2139-2147. (Pubitemid 350060351)
40. Koves, T.R., Ussher, J.R., Noland, R.C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J.R., Newgard, C.B., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56.
41. Labarthe, F., Khairallah, M., Bouchard, B., Stanley, W.C., and Des Rosiers, C. (2005). Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am. J. Physiol. Heart Circ. Physiol. 288, H1425-H1436. (Pubitemid 40270054)
42. Lee, L., Campbell, R., Scheuermann-Freestone, M., Taylor, R., Gunaruwan, P., Williams, L., Ashrafian, H., Horowitz, J., Fraser, A.G., Clarke, K., and Frenneaux, M. (2005). Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation 112, 3280-3288. (Pubitemid 43739373)
43. Lee, Y., Naseem, R.H., Duplomb, L., Park, B.H., Garry, D.J., Richardson, J.A., Schaffer, J.E., and Unger, R.H. (2004). Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc. Natl. Acad. Sci. USA 101, 13624-13629. (Pubitemid 39238453)
44. Lee, Y., Naseem, R.H., Park, B.H., Garry, D.J., Richardson, J.A., Schaffer, J.E., and Unger, R.H. (2006). Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice. Biochem. Biophys. Res. Commun. 344, 446-452.
45. Leichman, J.G., Aguilar, D., King, T.M., Vlada, A., Reyes, M., and Taegtmeyer, H. (2006). Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. Am. J. Clin. Nutr. 84, 336-341. (Pubitemid 44699142)
46. Lewin, T.M., de Jong, H., Schwerbrock, N.J., Hammond, L.E., Watkins, S.M., Combs, T.P., and Coleman, R.A. (2008). Mice deficient in mitochondrial glycerol- 3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition. Biochim. Biophys. Acta 1781, 352-358.
47. Liao, R., Jain, M., Cui, L., D'Agostino, J., Aiello, F., Luptak, I., Ngoy, S., Mortensen, R.M., and Tian, R. (2002). Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106, 2125-2131. (Pubitemid 35192820)
48. Listenberger, L.L., Han, X., Lewis, S.E., Cases, S., Farese, R.V., Jr., Ory, D.S., and Schaffer, J.E. (2003). Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 100, 3077-3082. (Pubitemid 36356542)
49. Liu, L., Shi, X., Bharadwaj, K.G., Ikeda, S., Yamashita, H., Yagyu, H., Schaffer, J.E., Yu, Y.H., and Goldberg, I.J. (2009). DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284, 36312-36323.
50. Liu, L., Yu, S., Khan, R.S., Ables, G.P., Bharadwaj, K.G., Hu, Y., Huggins, L.A., Eriksson, J.W., Buckett, L.K., Turnbull, A.V., et al. (2011). DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle. J. Lipid Res. 52, 732-744.
51. Lopaschuk, G.D., Ussher, J.R., Folmes, C.D., Jaswal, J.S., and Stanley, W.C. (2010). Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207-258.
52. Marfella, R., Di Filippo, C., Portoghese, M., Barbieri, M., Ferraraccio, F., Siniscalchi, M., Cacciapuoti, F., Rossi, F., D'Amico, M., and Paolisso, G. (2009). Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J. Lipid Res. 50, 2314-2323.
53. McGavock, J.M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., Levine, B.D., Raskin, P., Victor, R.G., and Szczepaniak, L.S. (2007). Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116, 1170-1175. (Pubitemid 47360218)
54. Meex, R.C., Schrauwen, P., and Hesselink, M.K. (2009). Modulation of myocellular fat stores: lipid droplet dynamics in health and disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R913-R924.
55. Nakae, I., Mitsunami, K., Yoshino, T., Omura, T., Tsutamoto, T., Matsumoto, T., Morikawa, S., Inubushi, T., and Horie, M. (2010). Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J. Card. Fail. 16, 812-822.
56. Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007). The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619-624. (Pubitemid 46828485)
57. Neely, J.R., Rovetto, M.J., and Oram, J.F. (1972). Myocardial utilization of carbohydrate and lipids. Prog. Cardiovasc. Dis. 15, 289-329.
58. Ng, A.C., Delgado, V., Bertini, M., van der Meer, R.W., Rijzewijk, L.J., Shanks, M., Nucifora, G., Smit, J.W., Diamant, M., Romijn, J.A., et al. (2009). Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am. J. Cardiol. 104, 1398-1401.
59. Nielsen, L.B., Véniant, M., Borén, J., Raabe, M., Wong, J.S., Tam, C., Flynn, L., Vanni-Reyes, T., Gunn, M.D., Goldberg, I.J., et al. (1998). Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98, 13-16. (Pubitemid 28312073)
60. Nöhammer, C., Brunner, F., Wölkart, G., Staber, P.B., Steyrer, E., Gonzalez, F.J., Zechner, R., and Hoefler, G. (2003). Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle. Lab. Invest. 83, 259-269. (Pubitemid 36255370)
61. O'Connor, R.D., Xu, J., Ewald, G.A., Ackerman, J.J., Peterson, L.R., Gropler, R.J., and Bashir, A. (2011). Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects. Magn. Reson. Med. 65, 1234-1238.
62. Ogata, T., Oishi, Y., Higuchi, M., and Muraoka, I. (2010). Fasting-related autophagic response in slow- and fast-twitch skeletal muscle. Biochem. Biophys. Res. Commun. 394, 136-140.
63. Okere, I.C., Chandler, M.P., McElfresh, T.A., Rennison, J.H., Kung, T.A., Hoit, B.D., Ernsberger, P., Young, M.E., and Stanley, W.C. (2007). Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet. Clin. Exp. Pharmacol. Physiol. 34, 113-119. (Pubitemid 46069595)
64. Okere, I.C., Chandler, M.P., McElfresh, T.A., Rennison, J.H., Sharov, V., Sabbah, H.N., Tserng, K.Y., Hoit, B.D., Ernsberger, P., Young, M.E., and Stanley, W.C. (2006a). Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am. J. Physiol. Heart Circ. Physiol. 291, H38-H44.
65. Okere, I.C., Young, M.E., McElfresh, T.A., Chess, D.J., Sharov, V.G., Sabbah, H.N., Hoit, B.D., Ernsberger, P., Chandler, M.P., and Stanley, W.C. (2006b). Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 48, 1116-1123. (Pubitemid 44772716)
66. Osuga, J., Ishibashi, S., Oka, T., Yagyu, H., Tozawa, R., Fujimoto, A., Shionoiri, F., Yahagi, N., Kraemer, F.B., Tsutsumi, O., and Yamada, N. (2000). Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. USA 97, 787-792. (Pubitemid 30070388)
67. Park, S.Y., Cho, Y.R., Kim, H.J., Higashimori, T., Danton, C., Lee, M.K., Dey, A., Rothermel, B., Kim, Y.B., Kalinowski, A., et al. (2005). Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54, 3530-3540. (Pubitemid 43334346)
68. Park, T.S., Hu, Y., Noh, H.L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.C., Abel, E.D., and Goldberg, I.J. (2008). Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49, 2101-2112.
69. Paul, A., Chan, L., and Bickel, P.E. (2008). The PAT family of lipid droplet proteins in heart and vascular cells. Curr. Hypertens. Rep. 10, 461-466.
70. Perman, J.C., Boström, P., Lindbom, M., Lidberg, U., StÅhlman, M., Hägg, D., Lindskog, H., Scharin Täng, M., Omerovic, E., Mattsson Hultén, L., et al. (2011). The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J. Clin. Invest. 121, 2625-2640.
71. Razani, B., Zhang, H., Schulze, P.C., Schilling, J.D., Verbsky, J., Lodhi, I.J., Topkara, V.K., Feng, C., Coleman, T., Kovacs, A., et al. (2011). Fatty acid synthase modulates homeostatic responses to myocardial stress. J. Biol. Chem. 286, 30949-30961.
72. Regan, T.J., Lyons, M.M., Ahmed, S.S., Levinson, G.E., Oldewurtel, H.A., Ahmad, M.R., and Haider, B. (1977). Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Invest. 60, 884-899.
73. Rijzewijk, L.J., van der Meer, R.W., Lamb, H.J., de Jong, H.W., Lubberink, M., Romijn, J.A., Bax, J.J., de Roos, A., Twisk, J.W., Heine, R.J., et al. (2009). Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J. Am. Coll. Cardiol. 54, 1524-1532.
74. Schweiger, M., Schreiber, R., Haemmerle, G., Lass, A., Fledelius, C., Jacobsen, P., Tornqvist, H., Zechner, R., and Zimmermann, R. (2006). Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J. Biol. Chem. 281, 40236-40241. (Pubitemid 46041828)
75. Sharma, S., Adrogue, J.V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G.P., Frazier, O.H., and Taegtmeyer, H. (2004). Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18, 1692-1700. (Pubitemid 39463708)
76. Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A.M., and Czaja, M.J. (2009). Autophagy regulates lipid metabolism. Nature 458, 1131-1135.
77. Son, N.H., Park, T.S., Yamashita, H., Yokoyama, M., Huggins, L.A., Okajima, K., Homma, S., Szabolcs, M.J., Huang, L.S., and Goldberg, I.J. (2007). Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J. Clin. Invest. 117, 2791-2801. (Pubitemid 47529610)
78. Son, N.H., Yu, S., Tuinei, J., Arai, K., Hamai, H., Homma, S., Shulman, G.I., Abel, E.D., and Goldberg, I.J. (2010). PPARg-induced cardiolipotoxicity in mice is ameliorated by PPARa deficiency despite increases in fatty acid oxidation. J. Clin. Invest. 120, 3443-3454.
79. Stanley, W.C., Recchia, F.A., and Lopaschuk, G.D. (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129. (Pubitemid 40894649)
80. Stowe, K.A., Burgess, S.C., Merritt, M., Sherry, A.D., and Malloy, C.R. (2006). Storage and oxidation of long-chain fatty acids in the C57/BL6 mouse heart as measured by NMR spectroscopy. FEBS Lett. 580, 4282-4287. (Pubitemid 44037585)
81. Suzuki, J., Shen, W.J., Nelson, B.D., Patel, S., Veerkamp, J.H., Selwood, S.P., Murphy, G.M., Jr., Reaven, E., and Kraemer, F.B. (2001). Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am. J. Physiol. Endocrinol. Metab. 281, E857-E866.
82. Suzuki, J., Shen, W.J., Nelson, B.D., Selwood, S.P., Murphy, G.M., Jr., Kanehara, H., Takahashi, S., Oida, K., Miyamori, I., and Kraemer, F.B. (2002). Cardiac gene expression profile and lipid accumulation in response to starvation. Am. J. Physiol. Endocrinol. Metab. 283, E94-E102. (Pubitemid 34686673)
83. Suzuki, J., Ueno, M., Uno, M., Hirose, Y., Zenimaru, Y., Takahashi, S., Osuga, J.-i., Ishibashi, S., Takahashi, M., Hirose, M., et al. (2009). Effects of hormone-sensitive lipase disruption on cardiac energy metabolism in response to fasting and refeeding. Am. J. Physiol. Endocrinol. Metab. 297, E1115-E1124.
84. Szczepaniak, L.S., Dobbins, R.L., Metzger, G.J., Sartoni-D'Ambrosia, G., Arbique, D., Vongpatanasin, W., Unger, R., and Victor, R.G. (2003). Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn. Reson. Med. 49, 417-423. (Pubitemid 36262808)
85. Szczepaniak, L.S., Victor, R.G., Orci, L., and Unger, R.H. (2007). Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ. Res. 101, 759-767. (Pubitemid 350287190)
86. Tuunanen, H., Engblom, E., Naum, A., Någren, K., Hesse, B., Airaksinen, K.E., Nuutila, P., Iozzo, P., Ukkonen, H., Opie, L.H., and Knuuti, J. (2006). Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114, 2130-2137. (Pubitemid 44747893)
87. Tuunanen, H., Engblom, E., Naum, A., Någren, K., Scheinin, M., Hesse, B., Juhani Airaksinen, K.E., Nuutila, P., Iozzo, P., Ukkonen, H., et al. (2008). Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation 118, 1250-1258.
88. Ueno, M., Suzuki, J., Zenimaru, Y., Takahashi, S., Koizumi, T., Noriki, S., Yamaguchi, O., Otsu, K., Shen, W.J., Kraemer, F.B., and Miyamori, I. (2008). Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice. Am. J. Physiol. Endocrinol. Metab. 294, E1109-E1118.
89. Unger, R.H., and Orci, L. (2001). Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15, 312-321. (Pubitemid 32141423)
90. Viljanen, A.P., Karmi, A., Borra, R., Pärkkä, J.P., Lepomäki, V., Parkkola, R., Lautamäki, R., Järvisalo, M., Taittonen, M., Rönnemaa, T., et al. (2009). Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults. Am. J. Cardiol. 103, 1721-1726.
91. Wang, H., Knaub, L.A., Jensen, D.R., Young Jung, D., Hong, E.G., Ko, H.J., Coates, A.M., Goldberg, I.J., de la Houssaye, B.A., Janssen, R.C., et al. (2009). Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 58, 116-124.
92. Wang, H., Sreenevasan, U., Hu, H., Saladino, A., Polster, B.M., Lund, L.M., Gong, D.W., Stanley, W.C., and Sztalryd, C. (2011). Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria. J. Lipid Res. 52, 2159-2168.
93. Wilson, C.R., Tran, M.K., Salazar, K.L., Young, M.E., and Taegtmeyer, H. (2007). Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem. J. 406, 457-467. (Pubitemid 47425452)
94. Yagyu, H., Chen, G., Yokoyama, M., Hirata, K., Augustus, A., Kako, Y., Seo, T., Hu, Y., Lutz, E.P., Merkel, M., et al. (2003). Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111, 419-426. (Pubitemid 36182219)
95. Yan, J., Young, M.E., Cui, L., Lopaschuk, G.D., Liao, R., and Tian, R. (2009). Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119, 2818-2828.
96. Yang, J., Sambandam, N., Han, X., Gross, R.W., Courtois, M., Kovacs, A., Febbraio, M., Finck, B.N., and Kelly, D.P. (2007). CD36 deficiency rescues lipotoxic cardiomyopathy. Circ. Res. 100, 1208-1217. (Pubitemid 46684134)
97. Yokoyama, M., Yagyu, H., Hu, Y., Seo, T., Hirata, K., Homma, S., and Goldberg, I.J. (2004). Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse. J. Biol. Chem. 279, 4204-4211. (Pubitemid 38199007)